Adaptive Biotechnologies Corp ($ADPT)
Filing Information
| Accession Number | 0001780660-26-000003 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 15, 2026 |
| Document Date | Jan 12, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
238,770
Total Value
$2,025,152.69
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief People Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 36,650 | $7.80 | $285,870.00 | 352,628 | Direct | โ | View Details | |
Chief People Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 7,723 | $12.14 | $93,757.22 | 360,351 | Direct | โ | View Details | |
Chief People Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 21,002 | $8.46 | $177,676.92 | 381,353 | Direct | โ | View Details | |
Chief People Officer | Common Stock | โ | Jan 12, 2026 | Exercise/Conversion | 14,215 | $3.99 | $56,717.85 | 395,568 | Direct | โ | View Details | |
Chief People Officer | Common Stock | โ | Jan 12, 2026 | Sale | 79,590 | $17.73 | $1,411,130.70 | 315,978 | Direct | โ | View Details | |
Chief People Officer | Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 36,650 | $0.00 | $0.00 | 75,500 | Direct | โ | View Details | |
Chief People Officer | Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 7,723 | $0.00 | $0.00 | 177,615 | Direct | โ | View Details | |
Chief People Officer | Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 21,002 | $0.00 | $0.00 | 87,074 | Direct | โ | View Details | |
Chief People Officer | Stock Option (right to buy) | Derivative | Jan 12, 2026 | Exercise/Conversion | 14,215 | $0.00 | $0.00 | 90,641 | Direct | โ | View Details |